Priced, coded and regulated ahead of the sales. Issue 02
“The next phase of BCI will be defined by more than technology alone.”
Michael Mager, Co-founder and CEO, Precision Neuroscience, 24 September 2026
However fast AI and networks are today, a digital bit still has to be read by an eye, heard by an ear, or typed by a thumb. In the six months to 30 September, companies started putting money and code behind the channels into and out of the human brain.
The world's first approved invasive brain-computer interface sold thirteen sets in its first three months of sales. But the larger commercial opening came outside the operating room: a developer toolkit, money for brain-data models, a prescription headset used at home and new privacy law. That is where most businesses will meet this technology first.
For invasive implants, the institutions are well ahead of the sales. BCIs are being priced, coded and regulated before they are sold.
Dargentic Intelligence Issue 02 sets out what actions to take over the next 6–18 months.
Executive Brief · Perspective · News Beat: Q2–Q3 2026
Guest View: BCI Reflections from a Busy Summer, by Naveen Rao · Competitive Map · Capital Funds Trials, Factories and Listings
Neural Input Opens to Business · Home Headsets and Clinic Hardware · Speech Implants and Personal Voice Software · For Approved BCIs, Payers Now Set the Clock · Who Owns the Brain Data That Trains AI
The Emotion Economy, Measured · Dreams, Calm and Presence Go on Sale · A Neural Souvenir
BCI Becomes a National-Security Issue · Four Regulatory Postures · China Built the Market Before the Product · Neural-Data Rules Reach Work and Wearables First · NERVE: Five Ways to Attack a BCI
Decisions for the Next 6–18 Months · Forward Radar: What We Are Watching · Scorecard: Our Issue 01 Theses
Plus Sources, Method and Corrections.
Relevant coverage in this report is accompanied by a signal box, graded by how soon it calls for action:
Structural change. Requires strategic response.
Accelerating trend. Position now.
Early indicator. Track and plan, do not act prematurely.
Previews. Select a page to enlarge.
Guest view · Page 8
“Public investors are pricing neurotech on revenue, while private BCI capital is still pricing on promise.”
Naveen Rao is the founder of Neurotech Futures, a publication and business ecosystem reaching thousands of readers worldwide, and writes about neurotechnology for Forbes.
From the Executive Brief, page 4.
Implant sales have begun at Neuracle; most capital is still in trials.
Dargentic Intelligence tracks the commercial, regulatory and strategic implications of brain-computer interfaces. We publish twice-yearly intelligence reports for business leaders, investors and policymakers in the industries the neural channel will reach.
The analysis draws on regulatory filings, exchange disclosures, clinical trial registries, legislative records, funding disclosures and direct engagement with the BCI industry. Key figures are labeled by evidence grade: measured, company-reported, planned or undisclosed.
Dargentic Intelligence is editorially independent and does not accept funding or sponsorship from the companies it covers.
Issue 02, Fall 2026. Published 31 October 2026. 32 pages. Data cutoff: 30 September 2026. Published twice a year. Issue 03: Spring 2027.
Data to 30 September 2026. Prices in US dollars.
Five seats and a 60-minute private video briefing with Velco Dar.
Order

Both reports as single-user PDFs: Issue 01, The Takeoff Era, and Issue 02, The Infrastructure Race. Delivered together in one email.
Issue 02 is available at no cost to qualifying institutions: government policy teams, regulatory bodies, speaker bureaus, and tier-one media. Request from reports@dargentic.com.
Also from Dargentic